Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

39.68
Delayed Data
As of Dec 02
 +0.61 / +1.56%
Today’s Change
25.98
Today|||52-Week Range
39.98
+23.08%
Year-to-Date
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
Haemonetics: Medical Center of Plano Picks BloodTrack
Nov 22 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Hits a 52-Week High on Solid Prospects
Nov 28 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close39.07
Today’s open39.12
Day’s range38.91 - 39.96
Volume277,234
Average volume (3 months)362,248
Market cap$2.0B
Dividend yield--
Data as of 4:02pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-8.04%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.02%
P/E ratioNM
Price/Sales1.97
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
GMEDGlobus Medical Inc+0.12+0.55%
PODDInsulet Corp+0.55+1.68%
PENPenumbra Inc-0.05-0.08%
HYHHalyard Health Inc+1.07+2.92%
Data as of 4:02pm ET, 12/02/2016

Financials

Next reporting dateFebruary 6, 2017
EPS forecast (this quarter)$0.40
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Chief Financial Officer
William P. Burke
Corporate headquarters
Braintree, Massachusetts

Forecasts


Search for Jobs